New 1,1-diarylethylene FOXM1 inhibitors potently reduce intracellular FOXM1 and suppress high-grade serous ovarian carcinoma cell viability

Cassie Liu(Stony Brook University Hospital), Adam R. Karpf(University of Nebraska Medical Center)
Research Square
January 25, 2022
Cited by 2


Related Papers